These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
Genes to Therapies (G2T), Alzheimer’s Disease Drug Discovery & Development (AD4) and General Scientific Support |
2022 $177,675 |
|
Genes to Therapies™ (G2T), Alzheimer’s Disease Drug Discovery & Development (AD4), ACTFAST and General Scientific Support |
2021 $172,500 |
|
Genes to Therapies (G2T) Centralized Research Core Oversight |
2014 to 2020 $1,233,640 |